Home / Stocks / HRMY

HRMY insider trading

Harmony Biosciences Holdings, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-01-23Kapadia Sandip
CHIEF FINANCIAL OFFICER
Sold25,000$40.18$1.0M
2025-01-21Dierks Jeffrey
CHIEF COMMERCIAL OFFICER
Sold29,475$37.41$1.1M
2024-11-05Gracias Antonio J.
Director · 10% owner
Sold4,600,000$30.30$139.4M
2024-11-05Marshman Fund Trust II
10% owner
Sold4,600,000$30.30$139.4M
2024-10-07Dierks Jeffrey
CHIEF COMMERCIAL OFFICER
Sold35,652$35.05$1.2M
2024-10-01Dierks Jeffrey
CHIEF COMMERCIAL OFFICER
Sold35,846$40.03$1.4M

See HRMY on the chart

Every insider buy and sell for HRMY plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.